Biohaven signs Ono deal worth up to $100 million
Biohaven (NYSE:BHVN) entered an exclusive regional licensing agreement with Ono Pharmaceutical covering its IgG degrader portfolio, with near-term payments of up to $100 million.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Biohaven (NYSE:BHVN) entered an exclusive regional licensing agreement with Ono Pharmaceutical covering its IgG degrader portfolio, with near-term payments of up to $100 million.
XPENG (NYSE:XPEV) completed the first production trial of its G9L SUV at Magna’s Graz, Austria facility, making it the fourth XPENG model to undergo production there.
LEIFRAS (NASDAQ:LFS) reported unaudited first-half fiscal 2026 revenue of JPY5,978.8 million for the six months ended June 30, up 8.9% from a year earlier.
argenx (NASDAQ:ARGX) said its Phase 2 study of FB102 in adults with celiac disease met its primary endpoint, showing a statistically significant improvement versus placebo at day 78 with a p-value of 0.0176.
argenx (NASDAQ:ARGX) will discontinue its Phase 3 UNITY study of subcutaneous efgartigimod in adults with moderate-to-severe Sjögren's disease after an interim analysis found the trial could not meet its primary endpoint.
CME Group (NASDAQ:CME) reported international average daily volume of 9 million contracts in the third quarter of 2026, up 22% from a year earlier.
Despite heightened uncertainty across the region, a new report from Savills finds that Abu Dhabi and Dubai continue to rank among the world's leading wealth destinations. The report evaluates more than 100 global locations on how well-placed they are to attract the next generation of wealth. Rachael Kennerley, Director of Research at Savills Middle East spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East & Africa.
Mauritius Commercial Bank reported an increase in net interest income for the full year that's as geopolitical tensions are driving up oil & gas prices. Jennifer Zabasajja, Bloomberg's Chief Africa Correspondent spoke to Thierry Hebraud, CEO of Mauritius Commercial Bank on the earnings and the formation of the new Africa Credit Ratings agency.
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.'s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. Bloomberg's Neil Campling has the details.
The European Union is taking a more assertive approach to China as the bloc's trade chief, Maros Sefcovic, heads into two days of negotiations in Beijing. The EU is preparing safeguards to limit imports of Chinese hybrid cars after their sales surged in Europe, which may be seen as an escalation. Bloomberg's Minmin Low and Oliver Crook break down the situation.
The European Union is striking a more assertive approach to China as the bloc's trade chief, Maros Sefcovic, heads into two days of negotiations in Beijing. The EU is preparing safeguards to limit imports of Chinese hybrid cars after their sales surged in Europe, which may be seen as an escalation. Bloomberg's Minmin Low and Oliver Crook break down the situation.
Hyperfine (NASDAQ:HYPR) expects preliminary unaudited third-quarter 2026 revenue of approximately $6 million, representing 53% sequential growth from the second quarter.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade